VENN THERAPEUTICS
Venn Therapeutics, a privately held immuno-oncology company focused on developing novel, early-stage cancer therapies, announced today that Dr. Stefani Spranger, Assistant Professor, Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, has been appointed to its scientific advisory board.
VENN THERAPEUTICS
Industry:
Biotechnology Oncology Pharmaceutical
Founded:
2015-01-01
Address:
Boulevard, California, United States
Country:
United States
Website Url:
http://www.venntherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Google Cloud Wix Unsplash
Similar Organizations
Acousia Therapeutics
Acousia Therapeutics is a privately held biotech company.
BioVersys
BioVersys is a privately held Swiss biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
KBP Biosciences
A multinational clinical stage biotechnology company.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
TuHURA Biosciences
TuHURA Biosciences is a phase 3 registration-stage immuno-oncology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.venntherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Venn Therapeutics"
Venn Therapeutics | Venn Therapeutics
Venn Therapeutics is a precision medicine company with a broad platform of scientific inquiry targeting cutting edge immuno-oncology (IO). We are developing a pipeline of novel, best-in โฆSee details»
Venn Therapeutics - Crunchbase Company Profile & Funding
Venn Therapeutics is a privately held immuno-oncology company. View contacts for Venn Therapeutics to access new leads and connect with decision-makers.See details»
Venn Acquires Cancer Immunotherapy Antibody - Innovation โฆ
Venn Therapeutics has completed an exclusive licensing deal with the University of California, San Francisco (UCSF) to advance its novel integrin ฮฑvฮฒ8 antibody, created by a team of โฆSee details»
Venn acquires a novel integrin ฮฑvฮฒ8 antibody precisely targeting โฆ
Apr 23, 2018ย ยท Venn Therapeutics, a privately held emerging biopharmaceutical company focused on turning โcoldโ tumors โhotโ, has completed an exclusive licensing deal with the University of โฆSee details»
Venn Therapeutics - LinkedIn
Venn Therapeutics is an integrin therapeutics precision medicine company. We are developing a pipeline of novel, best-in-class agents that precisely target key mechanisms of cancer, fibrosis โฆSee details»
Venn Therapeutics, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Venn Therapeutics, LLC of Tampa, FL. Get the latest business insights from Dun & Bradstreet.See details»
The USF Tampa Bay Technology Incubator Welcomes Venn โฆ
Jan 4, 2017ย ยท Venn Therapeutics, is an immuno-priming company focused on developing novel, first-in-class drugs that polarize tumor-resident innate immune cells to an anti-tumor โฆSee details»
Venn Therapeutics - Contacts, Employees, Board Members
Venn Therapeutics has 1 current employee profile, Founder, Chairman & Chief Executive Officer Sam Shrivastava. Venn Therapeutics is a privately held immuno-oncology company.See details»
ABOUT - Venn Therapeutics
Venn Therapeutics is a precision medicine company with a broad platform of scientific inquiry targeting cutting edge immuno-oncology (IO). We are developing a pipeline of novel, best-in โฆSee details»
Venn Therapeutics: Next Generation Cancer Immunotherapy
May 14, 2018ย ยท Vennโs pipeline candidates are each designed to overcome the limitations of first generation therapies, including checkpoint inhibitors such as Keytruda and Opdivo. It is โฆSee details»
Venn Therapeutics - VentureRadar
Venn Therapeutics is a precision medicine company with a broad platform of scientific inquiry targeting cutting edge immuno-oncology (IO). We are developing a pipeline of novel, best-in โฆSee details»
Venn Therapeutics LLC - Drug pipelines, Patents, Clinical trials
100 Translational Medicine associated with Venn Therapeutics LLC. Boost your research with our corporation tree data.See details»
PIPELINE - Venn Therapeutics
At Venn Therapeutics, we are developing a pipeline of novel, best-in-class agents that precisely target key mechanisms of fibrosis and NASH. VTX-001 is a monoclonal antibody that โฆSee details»
Venn Therapeutics Company Profile - Office Locations ... - Craft
Venn Therapeutics is an immuno-oncology company developing a pipeline of agents that target key mechanisms of cancer and fibrosis. It uses integrins to link the intracellular and โฆSee details»
Venn Therapeutics - PitchBook
Developer of immuno-oncology therapies intended to target key mechanisms of cancer, fibrosis, and nonalcoholic steatohepatitis (NASH).See details»
venntherapeutics.com Reviews: Is this site a scam or legit?
Venn Therapeutics is a precision medicine company with a broad platform of scientific inquiry targeting cutting edge immuno-oncology (IO). We are developing a pipeline of novel, best-in โฆSee details»
Julia Hallisey | Venn Therapeutics
Julia Hallisey is Head of Corporate Development and Strategy for Venn Therapeutics, where she oversees funding strategy and corporate growth initiatives. Prior to joining Venn, Ms. Hallisey โฆSee details»
Working at Venn Therapeutics - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Venn Therapeutics, including salaries, reviews, office photos, and more. This is the Venn Therapeutics company profile. All โฆSee details»
Russian journalist convicted of cooperating with a foreign โฆ
2 days agoย ยท The organization has been fined millions of dollars by Russi and was outlawed in the country in February. Alsu Kurmasheva , a Radio Free Europe/Radio Liberty journalist with U.S โฆSee details»
SCIENCE - Venn Therapeutics
Oct 18, 2018ย ยท Our lead asset, VTX-001, is a monoclonal antibody that targets integrin avฮฒ6/1 and has shown single-agent activity in multiple preclinical cancer models, demonstrating promising โฆSee details»